Prominent production of IL-20 by CD68+/CD11c+ Myeloid-derived cells in psoriasis: Gene regulation and cellular effects

Journal of Investigative Dermatology

Volumn 126, Issue 7, 2006, Pages 1590-1599

  Wang, Frank ^a   Lee, Edmund ^a   Lowes, Michelle A ^a   Haider, Asifa S ^a   Fuentes Duculan, Judilyn ^a   Abello, Maria Veronica ^a   Chamian, Francesca ^a   Cardinale, Irma ^a   Krueger, James G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; BETA2 INTEGRIN; CD2 ANTIGEN; CD68 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 20; INTERLEUKIN 20 RECEPTOR ALPHA; INTERLEUKIN 20 RECEPTOR BETA; INTERLEUKIN RECEPTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DRUG RESPONSE; GENE INDUCTION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENETICS; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VITRO STUDY; INCUBATION TIME; INFLAMMATION; KERATINOCYTE; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MICROARRAY ANALYSIS; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSORIASIS; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; ANTIGENS, CD; ANTIGENS, CD11C; ANTIGENS, CD2; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTEGRIN BETA CHAINS; INTERFERON TYPE II; INTERLEUKINS; KERATINOCYTES; LEUKOCYTES; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSORIASIS; RECEPTORS, INTERLEUKIN; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745209428     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700310     Document Type: Article

References (30)

1. Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, Carollo S et al. (2001) Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104:9-19
2. Bowcock AM, Krueger JC (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699-711
3. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K et al. (2001) Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 10:1793-805
4. Chamian F, Lowes MA, Lin SL, Lee E, Kikuchi T, Gilleaudeau P et al. (2005) Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA 102:2075-80
5. de Fougerolles AR, Koteliansky VE (2002) Regulation of monocyte gene expression by the extracellular matrix and its functional implications. Immunol Rev 186:208-20
6. Dhodapkar KM, Kaufman JL, Ehlers M, Banerjee DK, Bonvini E, Koenig S et al. (2005) Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc Natl Acad Sci USA 102:2910-5
7. Dhodapkar KM, Krasovsky J, Williamson B, Dhodapkar MV (2002) Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J Exp Med 195:125-33
8. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC (2001) Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167:3545-9
9. Dumoutier L, Louahed J, Renauld JC (2000) Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 164:1814-9
10. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD et al. (2000) Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1:442-50
11. Gillitzer R, Wolff K, Tong D, Muller C, Yoshimura T, Hartmann AA et al. (1993) MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101:127-31
12. Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, Lowes MA et al. (2005) TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 175:2721-9
13. Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB (1996) The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci USA 93:9160-5
14. Kjeldsen CR, Stenderup K, Dagnaes-Hansen F, Steiniche T, Hasselager E, Iversen LF et al. (2005) Interleukin 20 controls psoriasis induction and maintenance in a human xenograft mouse model. J Invest Dermatol 124(4 Suppl):A9 (abstr.)
15. Knappe A, Hor S, Wittmann S, Fickenscher H (2000) Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol 74:3881-7
16. Lew W, Bowcock AM, Krueger JG (2004a) Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. Trends Immunol 25:295-305
17. Lew W, Lee E, Krueger JG (2004b) Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris. Br J Dermatol 150:668-676
18. Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, Nussbaum R et al. (2005) Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 102:19057-62
19. Lowes MA, Lew W, Krueger JG (2004) Current concepts in the immunopathogenesis of psoriasis. Dermatol Clin 22:349-69, vii
20. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765
21. Nakamura K, Yasaka N, Asahina A, Kato M, Miyazono K, Furue M et al. (1998) Increased numbers of CD68 antigen positive dendritic epidermal cells and upregulation of CLA (cutaneous lymphocyte-associated antigen) expression on these cells in various skin diseases. J Dermatol Sci 18:170-80
22. Oestreicher JL, Walters IB, Kikuchi T, Gilleaudeau P, Surette J, Schwertschlag U et al. (2001) Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 1:272-87
23. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J et al. (2002) Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 277:47517-23
24. Pulford KA, Sipos A, Cordell JL, Stross WP, Mason DY (1990) Distribution of the CD68 macrophage/myeloid associated antigen. Int Immunol 2:973-80
25. Rich BE, Kupper TS (2001) Cytokines: IL-20 - a new effector in skin inflammation. Curr Biol 11:R531-4
26. Romer J, Hasselager E, Norby PL, Steiniche T, Thorn Clausen J, Kragballe K (2003) Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J Invest Dermatol 121:1306-11
27. Wang F, Lew W, Krueger JG (2004) The therapy of psoriasis based on innate and adaptive immune mechanisms of disease pathogenesis. Giorn Ital Dermatol Venereol 139:207-30
28. Wei CC, Chen WY, Wang YC, Chen PJ, Lee JY, Wong TW et al. (2005) Detection of IL-20 and its receptors on psoriatic skin. Clin Immunol 117:65-72
29. Wittkowski KM, Lee E, Nussbaum R, Chamian FN, Krueger JG (2004) Combining several ordinal measures in clinical studies. Stat Med 23:1579-92
30. Zhou X, Krueger JG, Kao MC, Lee E, Du F, Menter A et al. (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13:69-78